Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Said

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Oncotarget|November 29, 2016
Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcomaManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Cancer Research|April 17, 2015
Genomic and Functional Analysis of the E3 Ligase PARK2 in GliomaDe-Chen Lin, Liang Xu, Ye Chen, et al.
International Journal of Cancer|November 21, 2012
The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancerAhmed Aribi, Sigal Gery, Dhong Hyun Lee, et al.
Clinical Transplantation|June 12, 2018
Clinical characteristics and outcomes of PTLD following intestinal transplantationLaura J Wozniak, Tian L Mauer, Robert S Venick, et al.
Human Pathology|January 7, 2012
Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implicationsThomas G Papathomas, Ioannis Venizelos, Cherie H Dunphy, et al.
Scientific Reports|December 15, 2025
Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Scientific Reports|August 31, 2017
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2016
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinomaMark Bi, Siming Zhao, Jonathan W Said, et al.
Plos One|September 1, 2012
Cutaneous papilloma and squamous cell carcinoma therapy utilizing nanosecond pulsed electric fields (nsPEF)Dong Yin, Wangrong G Yang, Jack Weissberg, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2013
Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFRManoj Garg, Deepika Kanojia, Ryoko Okamoto, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Oncotarget|November 29, 2016
Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcomaManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Cancer Research|April 17, 2015
Genomic and Functional Analysis of the E3 Ligase PARK2 in GliomaDe-Chen Lin, Liang Xu, Ye Chen, et al.
International Journal of Cancer|November 21, 2012
The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancerAhmed Aribi, Sigal Gery, Dhong Hyun Lee, et al.
Clinical Transplantation|June 12, 2018
Clinical characteristics and outcomes of PTLD following intestinal transplantationLaura J Wozniak, Tian L Mauer, Robert S Venick, et al.
Human Pathology|January 7, 2012
Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implicationsThomas G Papathomas, Ioannis Venizelos, Cherie H Dunphy, et al.
Scientific Reports|December 15, 2025
Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Scientific Reports|August 31, 2017
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2016
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinomaMark Bi, Siming Zhao, Jonathan W Said, et al.
Plos One|September 1, 2012
Cutaneous papilloma and squamous cell carcinoma therapy utilizing nanosecond pulsed electric fields (nsPEF)Dong Yin, Wangrong G Yang, Jack Weissberg, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2013
Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFRManoj Garg, Deepika Kanojia, Ryoko Okamoto, et al.
Pageof 13